Opus Genetics, Inc. (IRD)
4.80
-0.17
(-3.42%)
USD |
NASDAQ |
May 15, 16:00
4.805
0.00 (0.00%)
After-Hours: 20:00
Opus Genetics Market Cap : 390.70M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Keros Therapeutics, Inc. | 207.81M |
| Xilio Therapeutics, Inc. | 48.34M |
| ACADIA Pharmaceuticals, Inc. | 3.664B |
| Alnylam Pharmaceuticals, Inc. | 38.32B |
| Amgen, Inc. | 176.21B |
Market Cap Related Metrics
| PS Ratio | 29.12 |
| Price | 4.80 |
| Earnings Yield | -28.22% |